Products and
Pipeline

Takeda Oncology Products


Exkivity (Mobocertinib)

Exkivity (Mobocertinib)

EXKIVITY® (mobocertinib) is a kinase inhibitor indicated for the treatment of adult patients with locally..

Alunbrig (Brigatinib)

Alunbrig (Brigatinib)

ALUNBRIG® (brigatinib) is indicated for the treatment of adult patients with anaplastic lymphoma ki…

Iclusig (Ponatinib)

Iclusig (Ponatinib)

ICLUSIG® (ponatinib) is now indicated for adult patients with chronic phase-CML who are…

Ninlaro (Ixazomib)

Ninlaro (Ixazomib)

NINLARO® (ixazomib) is the first and only oral medication of its kind, a proteasome inhibitor, that…

Velcade (bortezomib)

Velcade (bortezomib)

VELCADE® (bortezomib) belongs to a class of medicines called proteasome inhibitors. It is approved by the…

Takeda Oncology Pipeline

phase 1

phase 2

phase 3

phase 4

Hematologic Malignancies

Solid Tumors

Multiple Myeloma

Leukemias

Lymphomas

Other Hematologic Malignancies

Non-Small Cell Lung Cancer

Other Solid Tumors

Chat with
Med Info!
chatbot
×

Takeda Live Chat

×
Confirm Exit?

On exiting, all chat history will be cleared